Table of contents
Volume 100, Issue 1
Published online 6 January 2009 (1-220)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Epidemiology |
Letters to the Editor
Minireviews
Antiangiogenic drugs in ovarian cancer FREE
G C Kumaran, G C Jayson and A R Clamp
Br J Cancer 100: 1-7; advance online publication, November 11, 2008; doi:10.1038/sj.bjc.6604767
Ethics and biobanks FREE
M G Hansson
Br J Cancer 100: 8-12; advance online publication, November 25, 2008; doi:10.1038/sj.bjc.6604795
Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer FREE
W M van Weerden, C Bangma and R de Wit
Br J Cancer 100: 13-18; advance online publication, December 16, 2008; doi:10.1038/sj.bjc.6604822
Molecular therapy for the treatment of hepatocellular carcinoma FREE
T F Greten, F Korangy, M P Manns and N P Malek
Br J Cancer 100: 19-23; advance online publication, November 18, 2008; doi:10.1038/sj.bjc.6604784
Clinical Studies
Recognition of skin malignancy by general practitioners: observational study using data from a population-based randomised controlled trial FREE
P Pockney, J Primrose, S George, N Jayatilleke, B Leppard, H Smith, P Little, R Kneebone and A Lowy
Br J Cancer 100: 24-27; doi:10.1038/sj.bjc.6604810
A phase I–II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma FREE
A Rocca, S Minucci, G Tosti, D Croci, F Contegno, M Ballarini, F Nolè, E Munzone, A Salmaggi, A Goldhirsch, P G Pelicci and A Testori
Br J Cancer 100: 28-36; doi:10.1038/sj.bjc.6604817
A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer FREE
M Michael, T Price, S Y Ngan, V Ganju, A H Strickland, A Muller, K Khamly, A D Milner, J Dilulio, A Matera, J R Zalcberg and T Leong
Br J Cancer 100: 37-43; advance online publication, December 16, 2008; doi:10.1038/sj.bjc.6604827
Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial FREE
G Huebner, H Link, C H Kohne, M Stahl, A Kretzschmar, S Steinbach, G Folprecht, H Bernhard, S E Al-Batran, P Schoffski, C Burkart, F Kullmann, B Otremba, M Menges, M Hoffmann, U Kaiser, A Aldaoud and A Jahn on behalf of the German CUP Study Group
Br J Cancer 100: 44-49; advance online publication, December 9, 2008; doi:10.1038/sj.bjc.6604818
Irinotecan plus carboplatin for patients with carcinoma of unknown primary site FREE
K Yonemori, M Ando, M Yunokawa, T Hirata, T Kouno, C Shimizu, K Tamura, N Katsumata, A Hirakawa, K Matsumoto, Y Yamanaka, H Arioka and Y Fujiwara
Br J Cancer 100: 50-55; advance online publication, December 16, 2008; doi:10.1038/sj.bjc.6604829
A prospective study of peri-diagnostic and surgical wait times for patients with presumptive colorectal, lung, or prostate cancer FREE
E Grunfeld, J M Watters, R Urquhart, K O'Rourke, J Jaffey, D E Maziak, C Morash, D Patel and W K Evans
Br J Cancer 100: 56-62; advance online publication, December 16, 2008; doi:10.1038/sj.bjc.6604819
The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer FREE
D A C Deans, B H Tan, S J Wigmore, J A Ross, A C de Beaux, S Paterson-Brown and K C H Fearon
Br J Cancer 100: 63-69; doi:10.1038/sj.bjc.6604828
Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: a randomised trial FREE
E M L Verschuur, E W Steyerberg, H W Tilanus, S Polinder, M-L Essink-Bot, K T C Tran, A van der Gaast, L P S Stassen, E J Kuipers and P D Siersema
Br J Cancer 100: 70-76; advance online publication, December 9, 2008; doi:10.1038/sj.bjc.6604811
Rising incidence of breast cancer among female cancer survivors: implications for surveillance FREE
I Soerjomataram, W J Louwman, L E M Duijm and J W W Coebergh
Br J Cancer 100: 77-81; advance online publication, December 9, 2008; doi:10.1038/sj.bjc.6604816
Identification of paediatric cancer patients with poor quality of life FREE
L Sung, R J Klaassen, D Dix, S Pritchard, R Yanofsky, B Dzolganovski, R Almeida and A Klassen
Br J Cancer 100: 82-88; advance online publication, December 9, 2008; doi:10.1038/sj.bjc.6604826
Translational Therapeutics
HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer FREE
G E Konecny, L Santos, B Winterhoff, M Hatmal, G L Keeney, A Mariani, M Jones, C Neuper, B Thomas, L Muderspach, D Riehle, H-J Wang, S Dowdy, K C Podratz and M F Press
Br J Cancer 100: 89-95; advance online publication, December 16, 2008; doi:10.1038/sj.bjc.6604814
ATP7A is a novel target of retinoic acid receptor 
2 in neuroblastoma cells FREE
A Bohlken, B B Cheung, J L Bell, J Koach, S Smith, E Sekyere, W Thomas, M Norris, M Haber, D B Lovejoy, D R Richardson and G M Marshall
Br J Cancer 100: 96-105; doi:10.1038/sj.bjc.6604833
LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model FREE
B Fuh, M Sobo, L Cen, D Josiah, B Hutzen, K Cisek, D Bhasin, N Regan, L Lin, C Chan, H Caldas, S DeAngelis, C Li, P-K Li and J Lin
Br J Cancer 100: 106-112; doi:10.1038/sj.bjc.6604793
Macrophages and Fc-receptor interactions contribute to the antitumour activities of the anti-CD40 antibody SGN-40 FREE
E Oflazoglu, I J Stone, L Brown, K A Gordon, N van Rooijen, M Jonas, C-L Law, I S Grewal and H-P Gerber
Br J Cancer 100: 113-117; advance online publication, December 9, 2008; doi:10.1038/sj.bjc.6604812
Molecular Diagnostics
Reversibility of apoptosis in cancer cells FREE
H L Tang, K L Yuen, H M Tang and M C Fung
Br J Cancer 100: 118-122; advance online publication, December 16, 2008; doi:10.1038/sj.bjc.6604802
BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast FREE
E K A Millar, L R Anderson, C M McNeil, S A O'Toole, M Pinese, P Crea, A L Morey, A V Biankin, S M Henshall, E A Musgrove, R L Sutherland and A J Butt
Br J Cancer 100: 123-133; advance online publication, December 9, 2008; doi:10.1038/sj.bjc.6604809
Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial–mesenchymal transition in ovarian carcinomas FREE
M Colomiere, A C Ward, C Riley, M K Trenerry, D Cameron-Smith, J Findlay, L Ackland and N Ahmed
Br J Cancer 100: 134-144; advance online publication, December 16, 2008; doi:10.1038/sj.bjc.6604794
Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients FREE
M I Galleges Ruiz, K Floor, S M Steinberg, K Grünberg, F B J M Thunnissen, J A M Belien, G A Meijer, G J Peters, E F Smit, J A Rodriguez and G Giaccone
Br J Cancer 100: 145-152; advance online publication, December 2, 2008; doi:10.1038/sj.bjc.6604781
Expression of uPAR mRNA in peripheral blood is a favourite marker for metastasis in gastric cancer cases FREE
Y Kita, T Fukagawa, K Mimori, Y Kosaka, K Ishikawa, T Aikou, S Natsugoe, M Sasako and M Mori
Br J Cancer 100: 153-159; advance online publication, December 2, 2008; doi:10.1038/sj.bjc.6604806
Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment FREE
M J Slade, R Payne, S Riethdorf, B Ward, S A A Zaidi, J Stebbing, C Palmieri, H D Sinnett, E Kulinskaya, T Pitfield, R T McCormack, K Pantel and R C Coombes
Br J Cancer 100: 160-166; advance online publication, November 25, 2008; doi:10.1038/sj.bjc.6604773
Epidemiology
Trends in the epidemiology of larynx and lung cancer in south-east England, 1985–2004 FREE
V H Coupland, P Chapman, K M Linklater, A Sehgal, H Møller and E A Davies
Br J Cancer 100: 167-169; advance online publication, November 18, 2008; doi:10.1038/sj.bjc.6604787
Incidence and mortality of incidental prostate cancer: a Swedish register-based study FREE
O Andrèn, H Garmo, L Mucci, S-O Andersson, J-E Johansson and K Fall
Br J Cancer 100: 170-173; advance online publication, December 16, 2008; doi:10.1038/sj.bjc.6604834
Second primary cancers in patients with skin cancer: a population-based study in Northern Ireland FREE
M M Cantwell, L J Murray, D Catney, D Donnelly, P Autier, M Boniol, C Fox, R J Middleton, O M Dolan and A T Gavin
Br J Cancer 100: 174-177; doi:10.1038/sj.bjc.6604842
The antecedents of biliary cancer: a primary care case–control study in the United Kingdom FREE
M J Grainge, J West, M Solaymani-Dodaran, G P Aithal and T R Card
Br J Cancer 100: 178-180; advance online publication, November 18, 2008; doi:10.1038/sj.bjc.6604765
Vegetable, fruit and antioxidant nutrient consumption and subsequent risk of hepatocellular carcinoma: a prospective cohort study in Japan FREE
N Kurahashi, M Inoue, M Iwasaki, Y Tanaka, M Mizokami and S Tsugane for the JPHC Study Group
Br J Cancer 100: 181-184; doi:10.1038/sj.bjc.6604843
Seasonality of birth in children with central nervous system tumours in Denmark, 1970–2003 FREE
L S Schmidt, K Grell, K Frederiksen, C Johansen, K Schmiegelow and J Schüz
Br J Cancer 100: 185-187; advance online publication, December 9, 2008; doi:10.1038/sj.bjc.6604813
Incidence and survival of childhood bone cancer in northern England and the West Midlands, 1981–2002 FREE
R Eyre, R G Feltbower, E Mubwandarikwa, H C Jenkinson, S Parkes, J M Birch, T O B Eden, P W James, P A McKinney, M S Pearce and R J Q McNally
Br J Cancer 100: 188-193; doi:10.1038/sj.bjc.6604837
Helicobacter species in cancers of the gallbladder and extrahepatic biliary tract FREE
C de Martel, M Plummer, J Parsonnet, L-J van Doorn and S Franceschi
Br J Cancer 100: 194-199; advance online publication, November 25, 2008; doi:10.1038/sj.bjc.6604780
Use of oral glucocorticoids and risk of skin cancer and non-Hodgkin's lymphoma: a population-based case–control study FREE
AØ Jensen, H F Thomsen, M C Engebjerg, A B Olesen, S Friis, M R Karagas and H T Sørensen
Br J Cancer 100: 200-205; advance online publication, November 25, 2008; doi:10.1038/sj.bjc.6604796
Mortality and cancer incidence following occupational radiation exposure: third analysis of the National Registry for Radiation Workers FREE
C R Muirhead, J A O'Hagan, R G E Haylock, M A Phillipson, T Willcock, G L C Berridge and W Zhang
Br J Cancer 100: 206-212; doi:10.1038/sj.bjc.6604825
Cancer in the offspring of female radiation workers: a record linkage study FREE
K J Bunch, C R Muirhead, G J Draper, N Hunter, G M Kendall, J A O'Hagan, M A Phillipson, T J Vincent and W Zhang
Br J Cancer 100: 213-218; doi:10.1038/sj.bjc.6604841
Letters to the Editor
Estimation of lead time and overdiagnosis in breast cancer screening FREE
P C Gøtzsche, K J Jørgensen, J Mæhlen and P-H Zahl
Br J Cancer 100: 219; doi:10.1038/sj.bjc.6604762
Reply: Estimation of lead-time and overdiagnosis in breast cancer screening FREE
S W Duffy, E Lynge and H Jonsson
Br J Cancer 100: 220; doi:10.1038/sj.bjc.6604824
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
